|
Resolution: standard / high Figure 1.
Involvement of AP-1 in MMP-9 expression with JEV infection of RBA cells. (A, B) Cells were pretreated with tanshinone for 1 h or transfected with siRNA of
scrambled (scrb), c-Jun, or c-Fos, and then infected with JEV for 16 h. The conditioned
media were used to determine MMP-9 expression by gelatin zymography. Cell lysates
were analyzed by western blot using an anti-c-Jun, anti-c-Fos, or anti-GAPDH antibody.
(C) Cells were pretreated with tanshinone for 1 h, and then incubated with JEV for
6 h. RNA samples were analyzed by RT-PCR to assess the levels of MMP-9 mRNA expression.
(D, E) Cells were transiently transfected with MMP-9-luc reporter gene, pretreated
with tanshinone (10 μM) for 1 h, and then incubated with JEV for 6 h. In addition,
cells were transfected with wild-type MMP-9 promoter and AP-1-mutated MMP-9 promoter,
and then incubated with JEV (moi = 1) for 6 h. MMP-9 promoter activity was determined
in the cell lysates. Data are expressed as mean ± S.E.M. for five independent experiments.
*P < 0.05; #P < 0.01, as compared with the cells exposed to JEV alone (A, D). #P < 0.01, as compared with cells transfected with wild-type MMP-9 promoter stimulated
by JEV (E).
Yang et al. Journal of Neuroinflammation 2012 9:12 doi:10.1186/1742-2094-9-12 |